Refine your search

Search Results within category "Heart & Vascular"

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

Search all categories

Suggestions within category "Heart & Vascular"


5 Study Matches

Hemodynamic-GUIDEd Management of Heart Failure (GUIDE-HF)

The GUIDE-HF Randomized arm is to determine if PA pressure-guided HF management using CARDIOMEMS improves health outcomes in NYHA Class II, III or IV heart failure patients with either elevated NT-proBNP and/or a prior heart failure hospitalization. The GUIDE=HF Single Arm is to determine the equivalence of the effect of PA pressure-guided HF management on health outcomes between NYHA Class III heart failure patients with elevated NT-proBNP only and those with a prior heart failure hospitalization only.
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT03387813
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
heart failure
heart failure hospitalization within 1 year
Medicare
Currently patient of HMC
Exclusion Criteria:
Currently on dialysis
Heart & Vascular
  Email this study information to me
  Contact the study team
  See more information
  Show all 2 locations

Study Locations

Hide all locations
Location
Hershey, PA
Reading, PA

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF)

This is a registry based clinical trial to assess whether the initiation of spironolactone plus standard of care compared to standard care alone improves outcomes in patients with heart failure with preserved ejection fraction.
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT02901184
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Diagnosed with heart failure by a physician
Ejection fraction 40% or higher
Exclusion Criteria:
Currently taking the medication Spironolactone
Pregnant or able to become pregnant
Using home oxygen
Currently on dialysis
Known significant heart valve disease
Heart & Vascular
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA

REducing Lung congestion symptoms using the V-wavE shunt in advanced heart failure (RELIEVE-HF)

The objective of the study is to provide reasonable assurance of safety and effectiveness of the V-Wave Interatrial Shunt System to improve clinical outcomes in a certain high-risk group of symptomatic patients suffering from heart failure.
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT03499236
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
18 years of age or older
Diagnosed by a physician and told that I have Heart Failure
Currently on medications for the treatment of HF
Have symptoms of HF such as shortness of breath, fatigue, inability to lie flat or reduced ability to exert myself
Have been hospitalized or treated in an emergency department within the past year for my HF
Exclusion Criteria:
Presently on kidney dialysis
Presently enrolled in another clinical research study for an investigational drug or device
Have had a heart transplant or am presently on a waiting list for a transplant
Have an implanted mechanical heart assist device (pump)
Heart & Vascular
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA

Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction (ANTHEM-HFrEF)

To assess the safety and efficacy of the VITARIA System when added to stable, guideline directed medical therapy for patients with heart failure and reduced left ventricular ejection fraction.
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT03425422
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Have an Ejection Fraction (EF) ≤ 35%
Exclusion Criteria:
Chronic (permanent) atrial fibrillation, or previous ablation for atrial fibrillation
Pregnant, planning on getting pregnant, or breastfeeding during the study
Previous or current implanted system or lead for vagus or other nerve stimulation
Heart failure due to congenital heart disease, hypertrophic obstructive cardiomyopathy, or infiltrative cardiomyopathy (e.g. amyloidosis, sarcoidosis)
Heart & Vascular
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA

Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms (ALIVE)

The purpose of the study is to demonstrate the safety and effectiveness of the BioVentrix Revivent TC System for the treatment of left ventricular antero-septal aneurysms/scars in patients with symptomatic heart failure due to a previous heart attack. If you have heart failure due to a previous heart attack, you can discuss with your primary cardiologist the location of your scar tissue, or you can discuss this study with a member of the study team who can have your echocardiogram reviewed by one of the study doctors.
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT02553785
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Age 18 and older
Have heart failure (cardiomyopathy) due to a previous heart attack
Have reduced functioning of your heart (ejection fraction of 45% or less)
Exclusion Criteria:
Previous organ transplant, or currently listed for a organ transplant
Pregnant or planning to become pregnant
Heart & Vascular
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA